Venture funds now own 59 percent of company.
Health Care + Med Tech
The biggest little drug store you never heard of became ubiquitous this spring.
Goodness Growth, formerly known as Vireo Health, has unveiled plans to explore psychedelics for the treatment of depression and other psychiatric disorders.
The medical device maker sells an implantable product aimed at treating heart failure.
The company’s heart failure device, known as HVAD, was associated with a higher frequency of “neurological adverse events” compared to other products on the market.
The company has had scattered initiatives in the past, but the latest program codifies all of its efforts under one umbrella.
The company, which hasn’t yet turned a profit, forecasts a multibillion-dollar market for its lab-made livers and kidneys.
The small-format clinics are set to open in St. Louis Park, Eden Prairie, and St. Paul.
In the last days of the 2021 legislative session, state lawmakers approved the sale of smokable cannabis for medical patients. Minnesota’s two medical marijuana manufacturers say the move will make the plant more affordable.
Company’s revenue topped $1.2 billion in 2020
Company projects full year sales near $1 billion.
Technology addresses post-surgical lower back pain without addictive opioids
That included a mix of private and public capital, according to the Golden Valley-based Medical Alley Association.
The Plymouth company’s stock is up 190% year-to-date.
Medtronic’s CEO and Michael Osterholm are among the 30 experts set to speak at the April 7 virtual, all-day event.
Minneapolis health plan startup has raised more than $1.5 billion in financing.
A new report from the Minnesota Hospital Association shows a steady increase in the percentage of hospitals with negative operating margins over the past two years.
The nonprofit has provided grants to 10 health-oriented businesses along Lake Street.